Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2025-12-28 @ 4:59 PM
Study NCT ID:
NCT06208735
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2023-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Sponsor:
British Columbia Cancer Agency
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-20
First Submit QC Date:
None
Study First Post Date:
2024-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED